Development and landscape of maintenance therapy after first-line treatment of advanced or metastatic urothelial carcinoma. Liu Z, Cong X, Chen C, Yin J, et al. Front Immunol 2025;16:1541213.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu Z, Cong X, Chen C, Yin J, et al. Development and landscape of maintenance therapy after first-line treatment of advanced or metastatic urothelial carcinoma. Front Immunol 2025;16:1541213.
PMID: 40821840